Brian DeSchuytner
2023
In 2023, Brian DeSchuytner earned a total compensation of $1.7M as Senior Vice President, Chief Operating Officer and Chief Financial Officer at Mersana Therapeutics, a 34% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $115,564 |
|---|---|
| Option Awards | $871,776 |
| Salary | $444,475 |
| Stock Awards | $299,400 |
| Other | $7,000 |
| Total | $1,738,215 |
DeSchuytner received $871.8K in option awards, accounting for 50% of the total pay in 2023.
DeSchuytner also received $115.6K in non-equity incentive plan, $444.5K in salary, $299.4K in stock awards and $7K in other compensation.
Rankings
In 2023, Brian DeSchuytner's compensation ranked 641st out of 2,978 executives tracked by ExecPay. In other words, DeSchuytner earned more than 78.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 641 out of 2,978 | 79th |
Division Manufacturing | 358 out of 1,637 | 78th |
Major group Chemicals And Allied Products | 246 out of 906 | 73rd |
Industry group Drugs | 242 out of 869 | 72nd |
Industry Pharmaceutical Preparations | 155 out of 627 | 75th |
Source: SEC filing on April 26, 2024.
DeSchuytner's colleagues
We found six more compensation records of executives who worked with Brian DeSchuytner at Mersana Therapeutics in 2023.
2023
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
2023
Martin Huber
Mersana Therapeutics
Chief Executive Officer
2023
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
2023
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
2023
Alejandra Carvajal
Mersana Therapeutics
Chief Legal Officer
2023
Mohan Bala
Mersana Therapeutics
Senior Vice President, Chief Development Officer
News
Mersana Therapeutics CEO Anna Protopapas' 2023 pay jumps 56% to $4.5M
April 26, 2024
Mersana Therapeutics CEO Anna Protopapas' 2022 pay falls 66% to $2.8M
April 28, 2023
Mersana Therapeutics CEO Anna Protopapas' 2021 pay jumps 226% to $8.3M
April 29, 2022
Mersana Therapeutics Chief Medical Officer Arvin Yang receives $4.5M in 2020
April 27, 2021
Mersana Therapeutics CEO Anna Protopapas' 2019 pay falls 33% to $1.7M
April 20, 2020